Expression of CD44 Alternative Splicing Variants in Primary and Lymph Node Metastatic Lesions of Gynecological Cancer

Hiroshima Journal of Medical Sciences

Volumn 46, Issue 1, 1997, Pages 21-29

  Yorishima, Tsutomu ^a   Nagai, Nobutaka ^a   Ohama, Koso ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44 variant 6; Endometrial adenocarcinoma cells; Ovarian carcinoma

Indexed keywords

HERMES ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; FEMALE; FEMALE GENITAL TRACT TUMOR; GENE EXPRESSION; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPH NODE METASTASIS; METASTASIS;

ALTERNATIVE SPLICING; ANTIGENS, CD44; FEMALE; GENE EXPRESSION; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; VARIATION (GENETICS);

EID: 0031090702     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Aruffo, A., Stamenkovic, I., Melnick, M., Underbill, C.B. and Seed, B. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
2. Birch, M., Mitchell, S. and Hart, I.R. 1991. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res. 51: 6660-6667.
3. Cannistra, S.A., Abu-Jawdeh, G., Niloff, J., Strobel, T., Swanson, L., Andersen, J. and Ottensmeier, C. 1995. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. Journal of Clinical Oncology 13: 1912-1921.
4. Carter, W.G. and Wayner, E.A. 1988. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expression in nucleated human Cells. J. Biol. Chem. 263: 4193-4201.
5. Denning, S.M., Le, P.T., Singer, K.H. and Haynes, B.F. 1990. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144: 7-15.
6. Faassen, A.E., Schrager, J.A., Klein, D.J., Oegema, T.R., Couch man, J.R. and McCarthy, J.B. 1992. A cell chondroitin sulfate proteoglycan immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J. Cell Biol. 116: 521-531.
7. Fujimori, Y., Yokoyama, S., Nimura, Y., Nakata, S., Ito, K., Asanuma, K., Fujimori, M. and Sugenoya, A, 1995. Investigation of CD44 splice variants between primary and metastatic lesions of gastric cancer. Proceedings of the Japanese Cancer Association: 356.
8. Fujita, N. and Sato, S. 1995. Expression of CD44 in endometrial cancer and metastasis. Japanese Journal of Clinical Medicine 53: 160-164.
9. Goi, T., Yamaguchi, A., Seki, K, Saitoh, M., Takeuti, K., Hirose, K., Nakagawara, G., Urano, T., Furukawa, K. and Shiku, H. 1995. Correlation between CD44v8-10 expression and the prognosis in human gastric cancer. Proceedings of the Japanese Cancer Association: 335.
10. Goldstein, L.A., Zhou, D.F.H., Picker, L.J., Minty, C.N., Bargatze, R.F., Ding, J.F. and Butcher, E.C. 1989. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56: 1063-1072.
11. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haußmann, I., Matzku, S., Wanzel, A., Ponta, H. and Herrlich, P. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 85: 13-24.
12. Haynes, B.F., Telen, M.J., Hale, L.P. and Denning, S.M. 1989. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10: 423-428.
13. Herrlich, P., Zöller, M., Pals, S.T. and Ponta, H. 1993. CD44 splice variants:metastases meet lymphocytes. Immunol. Today 14: 395-399.
14. Huet, S., Groux, H., Caillou, B., Valentin, H., Prieur, A. and Bernard, A. 1989. CD44 contributes to T cell activation. J. Immunol. 143: 798-801.
15. Jalkanen, S., Bargatze, R.F., Toyos, J. and Butcher, E.G. 1987. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105: 983-990.
16. Jalkanen, S. and Jalkanen, M. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116: 817-825.
17. John, T.S., Meyer, J., Idzerda, R. and Gallatin, W.M. 1990. Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60: 45-52.
18. Kainz, C., Kohlberger, P., Sliutz, G., Tempfer, C., Heinzl, H., Reinthaller, A., Breitenecker, G. and Koelbl, H. 1995. Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIB. GYNECOLOGIC ONCOLOGY 57: 383-387.
19. Kalomiris, E.L. and Bourguignon, L.Y.W. 1988. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J. Cell Biol. 106: 319-327.
20. Kanayama, H., Kan, M., Aki, M. and Kagawa, S. 1995. Expression of CD44 variant form in human renal cell carcinoma. Japanese Journal of Clinical Medicine 53: 154-159.
21. Koopman, G., Heider, K., Horst, E., Adolf, G.R., van den Berg, F., Helmut, P., Ponta, H., Herrlich, P. and Pals, S.T. 1993. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med. 177: 897-904.
22. Matsumura, Y., Sugiyama, M., Matsumura, S., Hayle, A.J., Robinson, P., Smith, J.C. and Tarin, D. 1995. Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J. Pathol. 177: 11-20.
23. Matsumura, Y. and Tarin, D. 1992. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058.
24. Miyake, K., Medina, K.L., Hayashi, S., Ono, S., Hamaoka, T. and Kincade, P.W. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171: 477-488.
25. Miyake, K., Underhill, C.B., Lesley, J. and Kincade, P.W. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 paticipates in hyaluronate recognition. J. Exp. Med. 172: 69-75.
26. Mulder, J.R., Kruyt, P.M., Sewnath, M., Costing, J., Seldenrijk, C.A., Weidema, W.F., Offerhaus, G.J.A. and Pals, S.T. 1994. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 344: 1470-1472.
27. Ota, T., Matsui, T., Kohno, H., Maeda, M., Tanino, M. and Odashima, S. 1994. Role of CD44 in the experimental metastasis B16BL6 melanoma cells. Proceedings of the Japanese Cancer Association: 278.
28. Pals, S.T., Horst, E., Scheper, R.J. and Meijer, C.J. 1989. Mechanisms of human lymphocyte migration and their role in the pathogenesis of disease. Immunol-Rev. 108: 111-133.
29. Screaton, G.R., Bell, M.V., Bell, J.I. and Jackson, D.G. 1993. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J. Biol. Chem. 268: 12235-12238.
30. Screaton, G.R., Bell, M.V., Jackson, D.G., Cornells, F.B., Gerth, U. and Bell, J.I. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 89: 12160-12164.
31. Shimizu, Y., Van Seventer, G.A., Siraganian, R., Wahl, L. and Shaw, S. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143: 2457-2463.
32. Stamenkovic, I., Amiot, M., Pesando, J.M. and Seed, B. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057-1062.
33. Sy, M.S., Guo, Y. and Stamenkovic, I. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174: 859-866.
34. Takeuehi, K., Yamagichi, A., Urano, T., Goi, T., Nakagawara, G. and Shiku, H. 1995. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn. J. Cancer Res. 86: 292-297.
35. Tanabe, K.K., Ellis, L.M. and Saya, H. 1993. Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726.
36. Tölg, C., Hoffmann, M., Herrlich, P. and Ponta, H. 1993. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21: 1225-1229.
37. Wielenga, V.J.M., Heider, K., Offerhaus, G.J.A., Adolf, G.R., van den Berg, F.M., Ponta, H., Herrlich, P. and Pals, S.T. 1993. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53: 4754-4756.
38. Yamaguti, A., Goi, T., Takeuchi, K., Saito, M., Isobe, Y., Nakagawara, G., Urano, T., Furukawa, K. and Shiku, H. 1994. Expression of CD44 splice variant containing exon v8-10 in colorectal cancers and its relasionship to prognosis. Proceedings of the Japanese Cancer Association: 273.
39. Yamaguti, A., Saito, M., Goi, T., Iida, A., Takeuchi, K., Hirose, K., Nakagawara, G., Urano, T., Furukawa, K. and Shiku, H. 1995. Expression of CD44 variant exons 8-10 in gastric cancer. Jpn. J. Cancer Res. 86: 1166-1171.